Back to Search

STEVEN STEINHUBL, MD

MD

Cardiovascular Disease Physician

NPI: 1033123633IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

39023(KY)
Cardiovascular Disease PhysicianPrimary

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

39023(KY)01089041A(IN)
Interventional Cardiology Physician

Internal Medicine — Interventional Cardiology

Code: 207RI0011X

39023(KY)

CMS Specialties

PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)

Education

OTHER

Class of 1988

Research & Publications (20)

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.
PMID 19293071·Ann Intern Med·2009
8-other
Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trials.
PMID 17973080·J Thromb Thrombolysis·2008
8-other
Why have antioxidants failed in clinical trials?
PMID 18474268·Am J Cardiol·2008
6-review
Transitioning patients from cangrelor to clopidogrel: pharmacodynamic evidence of a competitive effect.
PMID 17631948·Thromb Res·2008
2-rct
The evolving algorithm concerning higher-risk PCI (TEACH-PCI). Introduction.
PMID 17917616·Rev Cardiovasc Med·2007
8-other
Platelets as mediators of inflammation.
PMID 17258122·Hematol Oncol Clin North Am·2007
6-review
Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease.
PMID 17615799·Vasc Med·2007
6-review
Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
PMID 17614940·Cardiovasc Drug Rev·2007
6-review
Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs.
PMID 17584547·Am Heart J·2007
4-observational
Risk stratifying the acute coronary syndrome patient: a focus on treatable risk.
PMID 17917619·Rev Cardiovasc Med·2007
6-review
Clopidogrel bisulfate: in ST-segment elevation myocardial infarction: a viewpoint by Steven R Steinhubl.
PMID 17192133·Am J Cardiovasc Drugs·2006
8-other
Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies.
PMID 17224886·Rev Cardiovasc Med·2006
6-review
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention.
PMID 16516075·J Am Coll Cardiol·2006
2-rct
Prasugrel may be safe for further testing in people undergoing PCI. Commentary.
PMID 16380060·Evid Based Cardiovasc Med·2005
8-other
The role of the platelet in the pathogenesis of atherothrombosis.
PMID 16259528·Am J Cardiovasc Drugs·2005
6-review
Assessing platelet function during treatment with glycoprotein IIb/IIIa antagonists.
PMID 12878903·Coron Artery Dis·2003
6-review
What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
PMID 12796751·Am Heart J·2003
6-review
Antiplatelet therapy: aspirin.
PMID 12724581·J Invasive Cardiol·2003
6-review
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
PMID 12435254·JAMA·2002
3-trial
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study.
PMID 11382726·Circulation·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
3344 N Torrey Pines Ct, Suite 300
LA Jolla, CA 92037

Locations (2)

Practice Location

3344 N Torrey Pines Ct, LA Jolla, CA
(858) 554-5757

Practice Location

5177 MCCARTY LN, LAFAYETTE, IN
(765) 448-8000

Quick Facts

NPI
1033123633
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
4
Locations
2
Years in Practice
38
Publications
20

Are you this provider?

Claim Your Profile